摘要
将雄性小鼠随机分成对照组、模型组、吡拉西坦组(0.62g·kg-1·d-1)、AEWH高剂量组(2.0g·kg-1·d-1)、AEWH低剂量组(0.5g·kg-1·d-1)。采用Aβ1-42小鼠双侧脑室注射诱导AD模型小鼠。小鼠给予AEWH灌胃,连续治疗18d后取材,采用双抗体夹心法测定海马IL-1β水平。与对照组比较,模型组小鼠海马IL-1β水平明显升高(P<0.05);与模型组比较,AEWH高剂量组海马IL-1β水平明显降低(P<0.05)。说明AEWH高剂量(2.0g·kg-1·d-1)能降低IL-1β水平,AEWH通过抑制IL-1β在AD治疗中发挥重要作用。
Male mice were randomly divided into control group, model group, piracetam group +(0.62g · kg^-1· d^-1), AEWH high dose group (2.0g ·kg^-1· d^-1), AEWH low dose group (0.5g ·kg^-1·d^-1). A β 1-42 injected mice using two-ventricle induced mouse model of AD. AEWH mice were given orally, 18d drawn after continuous treatment, hippocampal IL-1β levels measured by double antibody sandwich assay. Compared with the control group, model group mouse hippocampal IL-1 β levels were significantly increased (P 〈0.05). Compared with the model group, AEWH high dose group of hippocampal IL-1β levels were significantly lower (P 〈0.05). Description AEWH high dose (2.0g· kg^-1 · d^-1) reduces IL-1β levels, AEWH by inhibiting IL-1β play an important role in the treatment of AD.
出处
《黑龙江科学》
2015年第1期14-15,共2页
Heilongjiang Science
基金
国家自然科学基金资助项目(81373777
81173599)
关键词
通天草水提物
阿尔茨海默病
白介素-1Β
Aqueous extract from waternut herb
Alzheimer's disease
Interleukin-1 β